Success Metrics

Clinical Success Rate
84.3%

Based on 70 completed trials

Completion Rate
84%(70/83)
Active Trials
11(9%)
Results Posted
49%(34 trials)
Terminated
13(10%)

Phase Distribution

Ph phase_2
13
10%
Ph not_applicable
29
23%
Ph early_phase_1
4
3%
Ph phase_1
27
22%
Ph phase_3
21
17%
Ph phase_4
28
22%

Phase Distribution

31

Early Stage

13

Mid Stage

49

Late Stage

Phase Distribution122 total trials
Early Phase 1First-in-human
4(3.3%)
Phase 1Safety & dosage
27(22.1%)
Phase 2Efficacy & side effects
13(10.7%)
Phase 3Large-scale testing
21(17.2%)
Phase 4Post-market surveillance
28(23.0%)
N/ANon-phased studies
29(23.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

73.7%

70 of 95 finished

Non-Completion Rate

26.3%

25 ended early

Currently Active

11

trials recruiting

Total Trials

125

all time

Status Distribution
Active(17)
Completed(70)
Terminated(25)
Other(13)

Detailed Status

Completed70
unknown13
Terminated13
Withdrawn12
Recruiting8
Not yet recruiting4

Development Timeline

Analytics

Development Status

Total Trials
125
Active
11
Success Rate
84.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 14 (3.3%)
Phase 127 (22.1%)
Phase 213 (10.7%)
Phase 321 (17.2%)
Phase 428 (23.0%)
N/A29 (23.8%)

Trials by Status

enrolling_by_invitation22%
unknown1310%
withdrawn1210%
completed7056%
not_yet_recruiting43%
terminated1310%
recruiting86%
active_not_recruiting32%

Recent Activity

Clinical Trials (125)

Showing 20 of 125 trialsScroll for more
NCT07336485Not Applicable

Impact of Forced Diuresis on the Residual Fragment Rate After Flexible Ureteroscopy for Management of Renal Stones

Completed
NCT06899061Phase 1

Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib

Active Not Recruiting
NCT05470283Phase 1

Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma

Active Not Recruiting
NCT07737964Phase 3

ACetazolamide in Patients With Heart Failure, to Decrease Weight and relIEVE Symptoms.

Not Yet Recruiting
NCT03511118

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Recruiting
NCT07726134Not Applicable

The Impact of Intraoperative Diuretic Use on Delayed Graft Function Following Deceased Donor Renal Transplantation

Not Yet Recruiting
NCT07550790Not Applicable

Contrast-Induced Acute Kidney Injury Prevention in Acute Heart Failure

Recruiting
NCT04481789Phase 1

Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study)

Completed
NCT07431866Phase 1

A Clinical Study of the Effect of MK-2828 on Rosuvastatin or Furosemide in Healthy People (MK-2828-005)

Completed
NCT06941415Phase 3

Bumetanide vs. Furosemide in Cirrhosis

Recruiting
NCT07648251Phase 2

Furosemide vs Placebo in Severe Preeclampsia Postpartum

Not Yet Recruiting
NCT07631780Not Applicable

SURE-HF: Urinary Sodium-Guided Diuretic Therapy in Heart Failure

Not Yet Recruiting
NCT04180397Phase 4

Controlled Fluid Removal in Critical Ill Patients With Fluid Overload in the Intensive Care Unit.

Recruiting
NCT05915286Phase 4

Diuretic Use in Hemodialysis Patients With Residual Renal Function

Terminated
NCT07568886Not Applicable

Albumin and Furosemide for Preventing Ovarian Hyperstimulation Syndrome in ICSI Patients

Completed
NCT07568574Not Applicable

Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes

Enrolling By Invitation
NCT03892148Phase 4

Protocol of Diuretics Use in Congestive Therapy in Heart Failure

Completed
NCT07348510Not Applicable

Diuretic Effect of Aminophylline and Furosemide in Adult Patients Undergoing Cardiac Surgical Procedures

Recruiting
NCT06036914Phase 2

A Study of Ultra High Dose Diuretics to Treat Heart Failure

Completed
NCT05741372Not Applicable

A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis

Completed

Drug Details

Intervention Type
DRUG
Total Trials
125